Daquan energy: the polysilicon sales volume in the first quarter is expected to increase by 72.33% - 76.98% year-on-year

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

Midea Completes Controlling Acquisition of Italian Medical Imaging Firm Esaote

Midea Group (美的集团) completed its acquisition of a controlling stake in Italian medical imaging company Esaote S.p.A. (百胜医疗) on October 9, the companies said. Esaote will join Midea Healthcare while continuing to operate as an independent business headquartered in Genoa, with research and manufacturing facilities in Italy and the Netherlands.

Pony.ai and Uber Plan London Tests for Gen-7 Robotaxis

Pony.ai (小马智行) and Uber (优步) said on October 8 that they plan to begin testing Pony.ai’s seventh-generation (Gen-7) robotaxis on London streets in the coming weeks. The announcement extends their European partnership, but sets out a testing plan rather than a launch date for passenger service.

Manus Parent Butterfly Effect Raises More Than $500 Million After Meta Deal Unwind

Butterfly Effect, the China-founded company behind AI agent Manus, has completed a funding round of more than US$500 million, the company announced on October 8. Boyu Capital and IDG Capital led the round, with existing investors Tencent, HSG and ZhenFund also participating. The company did not disclose its valuation or how it plans to use the proceeds.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.